WHAT YOU NEED TO KNOW ABOUT THE 2023 CLINICAL PRACTICE GUIDELINE

Original Air Date : December 8, 2023

In October, a new guideline on the management of osteoporosis for Canadian healthcare providers, was published in the Canadian Medical Association Journal (CMAJ). The guideline is intended for use by the general practitioner in the prevention, diagnosis and management of osteoporosis.

What does this guideline mean for Canadians and their bone health? What do you need to know?

Join Dr. Rowena Ridout as she presents an introduction to the new guideline with information on the main areas of focus: exercise, nutrition, fracture risk assessment, treatment and more.

PRESENTERS

Dr. Rowena Ridout

Dr. Rowena Ridout is a physician in the UHN/MSH Osteoporosis Programme and is an Assistant Professor of Medicine in the Division of Endocrinology & Metabolism at the University of Toronto. She has been involved in clinical research in osteoporosis including the attainment and maintenance of peak bone mass, the treatment of steroid-induced osteoporosis in children and interventions in the fracture clinic. Dr. Ridout is currently the Chair of Osteoporosis Canada’s Scientific Advisory Council (SAC) and has served on a number of committees, including 6 years as the medical advisor to COPN. She is also a member of the 2023 Clinical Practice Guideline Steering Committee. Dr. Ridout is actively involved in medical education at both the undergraduate and postgraduate levels.

MODERATORS

Kerry Grady

MHSC, Senior Manager, Scientific and Clinical Programs, Osteoporosis Canada

BACK TO OC REPLAY

STAY INFORMED

Get Osteoporosis updates, news and stories. We also inform you of upcoming events and live webinars, don’t miss out, join today!

First Name*
Last Name*
Email Address*
Enter Email Confirm Email
Address
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country
Hidden
Postal Code*
Postal Code
Hidden
Osteoporosis Canada depends on the generous support of partners, individuals who participate in our programs, donors and volunteers to help realize its vision and mission. The organization collects your personal information in order to contact you with program information, your volunteer submission, to process your donation, issue your tax receipt and provide periodic updates and information about the organization. You may withdraw your consent at any time.*
- * Yes, I consent to receive communications from Osteoporosis Canada
Osteoporosis Canada depends on the generous support of partners, individuals who participate in our programs, donors and volunteers to help realize its vision and mission. The organization collects your personal information in order to contact you with program information, your volunteer submission, to process your donation, issue your tax receipt and provide periodic updates and information about the organization. You may withdraw your consent at any time.
Consent*
Yes, I consent to receive communications from Osteoporosis Canada
Osteoporosis Canada depends on the generous support of partners, individuals who participate in our programs, donors and volunteers to help realize its vision and mission. The organization collects your personal information in order to contact you with program information, your volunteer submission, to process your donation, issue your tax receipt and provide periodic updates and information about the organization. You may withdraw your consent at any time.
Comments
This field is for validation purposes and should be left unchanged.

OC REPLAY WEBINARS – RECENT ITEMS

Biosimilar for Patients on Denosumab

This webinar will provide you with information about the recently approved biosimilar for denosumab by Health Canada. Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.

WATCH

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab. Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment p…

WATCH

Exercise Recommendations in the New Clinical Practice Guideline

The 2023 Clinical Practice Guideline on the Diagnosis and Management of Osteoporosis in Canada has key recommendations and good practice statements with emphasis on significant areas including exercise. Join Osteoporosis Canada as Dr. Lora Giangregorio shares information on physical activity and exercise for bone hea…

WATCH